ArticleFrontiers in neurology2023
Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units.
Finn Brüggemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it